Filter
42
Filtered Results: 42
Text search:
Bharat
Biotech
Featured
Recommendations
4
New Publications
11
Language
Document type
No document type
14
Guidelines
13
Studies & Reports
6
Fact sheets
5
Strategic & Response Plan
2
Situation Updates
1
Resource Platforms
1
Countries / Regions
India
16
Ukraine
2
Paraguay
2
Cameroon
1
Mozambique
1
Global
1
Africa
1
Latin America and the Carribbean
1
Germany
1
Brazil
1
Russia
1
Authors & Publishers
Publication Years
Category
COVID-19
12
Guidelines
6
Policies
4
Parasitology
3
Vaccine-preventable Diseases
2
Drugs & Medical Equipment
2
Studies & Reports
2
Malaria
2
Community Health
1
Virology
1
Community Health
1
Information, Education and Communication (IEC)
1
Diarrhoea
1
HIV & STI
1
Toolboxes
Immunization Guidelines
6
Covaxin
6
Country specific documents
3
Booster Doses
3
Country specific
2
Vaxzevria (Astra Zeneca)
2
Clinical Aspects, Treatment & Prevention
1
Vaccination
1
Pediatrics
1
Stroke
1
Clinical Guidelines
1
For Parents & Children
1
For Pregnant Women
1
Country Specific
1
Scientific & Research Studies
1
Access & Strategy
1
Moderna
1
Biontech/Pfizer Comirnaty
1
Johnson & Johnson
1
Sputnik V
1
Inactivated COVID-19 Vaccines
1
Situation Reports & Updates
1
Guidelines & Manuals
1
General
1
Access to treatment and laboratory
1
Health Financing Toolbox
1
Women
1
Recommendations for the adaptation of Emergency Medical Teams (EMTs) at temporary sites for COVID-19 vaccination. Draft Version 2.3, November 2021
Second Edition
AIDS Medicines and diagnostics services
July 2015
The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP), has produced this report as part of a solid com-mitment to develop actionable policy proposals to tackle antibiotic resistance and improve appropriate...
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de...
This document provides guidance on interventions to prevent vaccine-preventable disease outbreaks in the context of mass population movement resulting from the ongoing crisis in Ukraine.
interim guidance, 19 July 2021 (arabic version)
O Informe Semanal de Evidências sobre Variantes de Atenção do SARS-CoV-2 é uma produção organizada pelo Departamento de Ciência e Tecnologia da Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde do Ministério da Saúde (DECIT/SCTIE/MS). O documento tem o objetiv...
Antibiotics use with care
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
This report, published in conjunction with a summary overview of results of rounds 1–8, is the eighth and final report in a series of laboratory-based evaluations of rapid diagnostic tests (RDTs) for malaria. It provides a comparative measure of their performance in a standardized way to distingu...
India is experiencing rapid demographic and epidemiological transitions with NCDs causing significant disability, morbidity and mortality both in urban and rural populations and across all socioeconomic strata. According to the ICMR State Level Disease Burden Initiative, in 2016, NCDs accounted to a...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
Journal of The Association of Physicians of India, Vol. 63 November 2015,, pp.77-96
